{"entity":{"type":"insider","cik":"0001700786","url":"/insider/0001700786","json_url":"/insider/0001700786.json","name":"Moss Ronald B.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":11,"n_filings":11,"first":"2019-03-22","last":"2022-03-22","span_basis":"filed_date"},"name_variants":[{"name":"Moss Ronald B.","source":"filing","n_filings":11,"first_seen":"2019-03-22","last_seen":"2022-03-22"}],"transactions":[{"id":6448292,"accession":"0001387131-22-003863","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001387131-22-003863","line_url":"/filing/0001387131-22-003863#line-1","is_derivative":false,"issuer_cik":"0000887247","issuer_name":"Adamis Pharmaceuticals Corp","issuer_ticker":"ADMP","issuer_name_source":null,"issuer_url":"/issuer/0000887247","owner_cik":"0001700786","owner_name":"Moss Ronald B.","owner_url":"/insider/0001700786","role":"Officer (Chief Medical Officer)","officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8199.0,"shares_display":"8,199","price_per_share":0.6036,"price_display":"0.60","price_state":"stated","total_value":4948.9164,"total_display":"4,948.92","shares_owned_after":201911.0,"shares_owned_after_display":"201,911","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-03-18","filed_date":"2022-03-22","scope":"insider"},{"id":4754147,"accession":"0001387131-21-011777","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001387131-21-011777","line_url":"/filing/0001387131-21-011777#line-1","is_derivative":false,"issuer_cik":"0000887247","issuer_name":"Adamis Pharmaceuticals Corp","issuer_ticker":"ADMP","issuer_name_source":null,"issuer_url":"/issuer/0000887247","owner_cik":"0001700786","owner_name":"Moss Ronald B.","owner_url":"/insider/0001700786","role":"Officer (Chief Medical Officer)","officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":35553.0,"shares_display":"35,553","price_per_share":0.785,"price_display":"0.78","price_state":"stated","total_value":27909.105,"total_display":"27,909.10","shares_owned_after":210110.0,"shares_owned_after_display":"210,110","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-12-01","filed_date":"2021-12-03","scope":"insider"},{"id":3000904,"accession":"0001593968-20-002232","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001593968-20-002232","line_url":"/filing/0001593968-20-002232#line-1","is_derivative":false,"issuer_cik":"0000887247","issuer_name":"Adamis Pharmaceuticals Corp","issuer_ticker":"ADMP","issuer_name_source":null,"issuer_url":"/issuer/0000887247","owner_cik":"0001700786","owner_name":"Moss Ronald B.","owner_url":"/insider/0001700786","role":"Officer (Chief Medical Officer)","officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8532.0,"shares_display":"8,532","price_per_share":0.4061,"price_display":"0.41","price_state":"stated","total_value":3464.8452,"total_display":"3,464.85","shares_owned_after":231752.0,"shares_owned_after_display":"231,752","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-11-18","filed_date":"2020-11-20","scope":"insider"},{"id":3000850,"accession":"0001593968-20-001771","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001593968-20-001771","line_url":"/filing/0001593968-20-001771#line-1","is_derivative":false,"issuer_cik":"0000887247","issuer_name":"Adamis Pharmaceuticals Corp","issuer_ticker":"ADMP","issuer_name_source":null,"issuer_url":"/issuer/0000887247","owner_cik":"0001700786","owner_name":"Moss Ronald B.","owner_url":"/insider/0001700786","role":"Officer (Chief Medical Officer)","officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8749.0,"shares_display":"8,749","price_per_share":0.8741,"price_display":"0.87","price_state":"stated","total_value":7647.5009,"total_display":"7,647.50","shares_owned_after":226373.0,"shares_owned_after_display":"226,373","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-08-18","filed_date":"2020-08-20","scope":"insider"},{"id":2826818,"accession":"0001593968-20-001223","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001593968-20-001223","line_url":"/filing/0001593968-20-001223#line-1","is_derivative":false,"issuer_cik":"0000887247","issuer_name":"Adamis Pharmaceuticals Corp","issuer_ticker":"ADMP","issuer_name_source":null,"issuer_url":"/issuer/0000887247","owner_cik":"0001700786","owner_name":"Moss Ronald B.","owner_url":"/insider/0001700786","role":"Officer (Chief Medical Officer)","officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7736.0,"shares_display":"7,736","price_per_share":0.5601,"price_display":"0.56","price_state":"stated","total_value":4332.9336,"total_display":"4,332.93","shares_owned_after":235122.0,"shares_owned_after_display":"235,122","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-05-18","filed_date":"2020-05-20","scope":"insider"},{"id":2931221,"accession":"0001593968-20-000864","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001593968-20-000864","line_url":"/filing/0001593968-20-000864#line-1","is_derivative":false,"issuer_cik":"0000887247","issuer_name":"Adamis Pharmaceuticals Corp","issuer_ticker":"ADMP","issuer_name_source":null,"issuer_url":"/issuer/0000887247","owner_cik":"0001700786","owner_name":"Moss Ronald B.","owner_url":"/insider/0001700786","role":"Officer (Chief Medical Officer)","officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10337.0,"shares_display":"10,337","price_per_share":0.3366,"price_display":"0.34","price_state":"stated","total_value":3479.4342,"total_display":"3,479.43","shares_owned_after":242858.0,"shares_owned_after_display":"242,858","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-03-18","filed_date":"2020-03-19","scope":"insider"},{"id":3300317,"accession":"0001593968-20-000520","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001593968-20-000520","line_url":"/filing/0001593968-20-000520#line-1","is_derivative":false,"issuer_cik":"0000887247","issuer_name":"Adamis Pharmaceuticals Corp","issuer_ticker":"ADMP","issuer_name_source":null,"issuer_url":"/issuer/0000887247","owner_cik":"0001700786","owner_name":"Moss Ronald B.","owner_url":"/insider/0001700786","role":"Officer (Chief Medical Officer)","officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6229.0,"shares_display":"6,229","price_per_share":0.0635,"price_display":"0.06","price_state":"stated","total_value":395.5415,"total_display":"395.54","shares_owned_after":253195.0,"shares_owned_after_display":"253,195","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-02-24","filed_date":"2020-02-26","scope":"insider"},{"id":8559744,"accession":"0001593968-19-002188","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001593968-19-002188","line_url":"/filing/0001593968-19-002188#line-1","is_derivative":false,"issuer_cik":"0000887247","issuer_name":"Adamis Pharmaceuticals Corp","issuer_ticker":"ADMP","issuer_name_source":null,"issuer_url":"/issuer/0000887247","owner_cik":"0001700786","owner_name":"Moss Ronald B.","owner_url":"/insider/0001700786","role":"Officer (Chief Medical Officer)","officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8448.0,"shares_display":"8,448","price_per_share":0.852,"price_display":"0.85","price_state":"stated","total_value":7197.696,"total_display":"7,197.70","shares_owned_after":259424.0,"shares_owned_after_display":"259,424","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-11-18","filed_date":"2019-11-20","scope":"insider"},{"id":8354201,"accession":"0001593968-19-001775","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001593968-19-001775","line_url":"/filing/0001593968-19-001775#line-1","is_derivative":false,"issuer_cik":"0000887247","issuer_name":"Adamis Pharmaceuticals Corp","issuer_ticker":"ADMP","issuer_name_source":null,"issuer_url":"/issuer/0000887247","owner_cik":"0001700786","owner_name":"Moss Ronald B.","owner_url":"/insider/0001700786","role":"Officer (Chief Medical Officer)","officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8383.0,"shares_display":"8,383","price_per_share":1.0608,"price_display":"1.06","price_state":"stated","total_value":8892.6864,"total_display":"8,892.69","shares_owned_after":267872.0,"shares_owned_after_display":"267,872","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-08-19","filed_date":"2019-08-21","scope":"insider"},{"id":7849483,"accession":"0001593968-19-001170","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001593968-19-001170","line_url":"/filing/0001593968-19-001170#line-1","is_derivative":false,"issuer_cik":"0000887247","issuer_name":"Adamis Pharmaceuticals Corp","issuer_ticker":"ADMP","issuer_name_source":null,"issuer_url":"/issuer/0000887247","owner_cik":"0001700786","owner_name":"Moss Ronald B.","owner_url":"/insider/0001700786","role":"Officer (Chief Medical Officer)","officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8741.0,"shares_display":"8,741","price_per_share":1.7691,"price_display":"1.77","price_state":"stated","total_value":15463.7031,"total_display":"15,463.70","shares_owned_after":276255.0,"shares_owned_after_display":"276,255","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-05-20","filed_date":"2019-05-22","scope":"insider"},{"id":8687674,"accession":"0001593968-19-000837","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001593968-19-000837","line_url":"/filing/0001593968-19-000837#line-1","is_derivative":false,"issuer_cik":"0000887247","issuer_name":"Adamis Pharmaceuticals Corp","issuer_ticker":"ADMP","issuer_name_source":null,"issuer_url":"/issuer/0000887247","owner_cik":"0001700786","owner_name":"Moss Ronald B.","owner_url":"/insider/0001700786","role":"Officer (Chief Medical Officer)","officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6647.0,"shares_display":"6,647","price_per_share":2.268,"price_display":"2.27","price_state":"stated","total_value":15075.396,"total_display":"15,075.40","shares_owned_after":284996.0,"shares_owned_after_display":"284,996","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-03-20","filed_date":"2019-03-22","scope":"insider"}],"next_cursor":null,"ledger_fault":false,"count":{"value":11,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":11,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":11},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0000887247","name":"Adamis Pharmaceuticals Corp","url":"/issuer/0000887247","role":"Officer (Chief Medical Officer)","n_filings":11,"first_seen":"2019-03-22","last_seen":"2022-03-22"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001700786","retrieved_at":"2026-08-21T08:43:42+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-20","last_ingest":"2026-08-21T05:23:33.898496+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}